40 min ago
USC Eye Institute study finds African-Americans at higher risk for diabetic vision loss
Study points to need for improved screening and access to treatments for diabetic macular edema, a leading cause of vision loss Rohit Varma, M.D., M.P.H., is the director of the USC Eye Institute and professor and chair of ophthalmology at the Keck School of Medicine of USC.
Mon Aug 18, 2014
The Washington Post
Chugai Rises by Limit After Roche Said to Be in Buyout Talks
Chugai Pharmaceutical Co. jumped by the most in four decades after parent Roche Holding AG was said to be in talks to buy out the Japanese drugmaker to secure full control of its cancer and arthritis drugs.
Sat Aug 16, 2014
The Daily Record
Alzheimer's drug misses goals
An experimental drug from the biotech company Genentech failed to slow mental decline in mid-stage studies on more than 500 people with mild to moderate Alzheimer's disease, but showed some promise in the least-impaired participants who received a higher dose.
Fri Aug 15, 2014
Roche to offer $10 billion for rest of Chugai: Bloomberg
Roche Holding AG is in talks to buy the almost 40 percent stake in Japan's Chugai Pharmaceutical Co Ltd that it does not already own for about $10 billion, Bloomberg reported, citing people familiar with the matter.
Gilead beats back Roche, wins U.K. victory for hepatitis C drug Sovaldi
An arbitration panel ruled Friday that the Foster City-based drug maker's hepatitis C blockbuster Sovaldi did not infringe a 2004 research deal that rival Roche had with Pharmasset Inc. Gilead , led by Chairman and CEO John Martin , bought Pharmasset in 2012 for $11 billion, landing the drug that would become Sovaldi.
Thu Aug 14, 2014
Genentech wins approval to treat advanced cervical cancer
Genentech scored its latest victory Thursday when its drug Avastin won federal approval to treat yet another cancer, advanced cervical cancer.
Richard Scheller's rare African art head to de Young
A rare collection of African art assembled over nearly 30 years by a leading Genentech biochemist will go on display at the de Young Museum in Golden Gate Park in late January, marking the first time the public has seen many of the carved forms and shapes.
Wed Aug 13, 2014
Suitors line up for lung drug developer InterMune
InterMune Inc. , on the cusp of finally winning regulatory approval of its treatment for a fatal lung-scarring disease, may be the hottest acquisition target in biotech.
New York Daily News
Google 'anti-aging' group Calico has a website
Google's ambitious health-meets-tech spin-off, announced last fall by Google chief executive Larry Page, now has a website.
Tue Aug 12, 2014
Silicon Alley Insider
Google's Company That Wants To Cure Death Now Has Its Own Website
When Google CEO Larry Page first announced the new lab, he didn't give much of a roadmap for how Calico would work on extending human life.
Mon Aug 04, 2014
Combined Administration of RG7652, a Recombinant Human Monoclonal...
To whom correspondence should be addressed at: Genentech Inc., MS no. 59, South San Francisco, CA 94080.
Wed Jul 30, 2014
GRAMMYA Award-Winning Singer Jennifer Hudson Lends Her Voice To...
LOS ANGELES and NEW YORK, July 30, 2014 /PRNewswire-USNewswire/ -- Stand Up To Cancer , a program of the Entertainment Industry Foundation, and Genentech, one of the world's leading biotech companies, have joined forces with GRAMMY -winning singer, Oscar -winning actress, and SU2C Ambassador Jennifer Hudson for their latest campaign, entitled: "Two ... (more)
Thu Jul 24, 2014
Cypher Genomics Appoints to the Board of Directors, Henry Nordhoff as ...
Cypher Genomics, Inc., the genome informatics company, announced today the appointment of Henry Nordhoff as executive chairman of Cypher's board of directors.
Community Impact: bringing students face to face with the world's top scientists
What better way to get students interested in science than to bring them into one of the top biotechs in the world? Genentech's Gene Academy shuttles students from three South San Francisco elementary schools and one middle school to the Genentech campus once a week for help with homework and projects as well as to talk with scientists at their ... (more)
Roche Profit Falls on Franc Strengthl New-Drug Sales Rise
Roche Holding AG 's first-half profit fell 7 percent as the strength of the Swiss franc offset rising sales of the drugmaker's new cancer medicines.
Wed Jul 23, 2014
Roche profit dented by currencies
Roche Holding AG reported Thursday that first-half net profit slid 7% under pressure from exchange rates, but strong sales of its cancer therapies prompted the Swiss drug giant to confirm its outlook for the full year.
Ottawa cancer lab part of 'stepping into this future,' newly recruited director says
Dr. Lo has just been recruited by the Ottawa Hospital to open this city's first molecular oncology lab - a lab devoted to diagnosing the genetics of cancer.
Mon Jul 21, 2014
Donaco International Limited (ASX:DNA) On-Market Buy-Back and Appendix 3C
The buy-back is being undertaken as part of the Company's ongoing capital management program.
Asthma Drug May Help Those With Chronic Hives
A drug already used to treat moderate-to-severe allergic asthma appears to offer relief to people with chronic hives who haven't been helped by standard medications, new research suggests.